Status:
UNKNOWN
Feasibility of Frailty Assessment and Implementation of Interventions in Women Over 70 With Epithelial Ovarian Cancer
Lead Sponsor:
Royal Marsden NHS Foundation Trust
Conditions:
Ovarian Cancer
Chemotherapy
Eligibility:
FEMALE
70+ years
Phase:
NA
Brief Summary
Ovarian cancer is frequently diagnosed in older women, with over half of all new diagnoses being in women over 65 years. Current treatment options are based on the results of clinical trials that ofte...
Detailed Description
FAIR-O is a single-arm, multi-center, phase II intervention trial of a geriatric assessment in older patients (≥ 70 years old) diagnosed with epithelial ovarian, fallopian tube or primary peritoneal c...
Eligibility Criteria
Inclusion
- Age at time of consideration for systemic chemotherapy of 70 years and above
- Histological or cytological confirmation of epithelial ovarian cancer
- Planning to commence systemic chemotherapy for either newly diagnosed epithelial ovarian cancer or first disease relapse
- Life expectancy greater than 3 months
- Able to give informed consent, complete questionnaires in english and comply with study procedures
Exclusion
- In the opinion of the investigator, patient is not fit for systemic chemotherapy or patient declines systemic chemotherapy
- Patient does not have the capacity to consent for enrollment into the study or capacity to consent for systemic chemotherapy
Key Trial Info
Start Date :
June 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04300699
Start Date
June 1 2020
End Date
December 1 2022
Last Update
March 9 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.